SUPPLEMENT DATED DECEMBER 13, 2000
TO
PROSPECTUS DATED AUGUST 1, 2000
THE SUB-SECTION OF THE FUND'S PROSPECTUS DESCRIBING "CLASS A SHARES", ON PAGE __
OF THE PROSPECTUS AND APPEARING UNDER THE HEADING, "HOW TO BUY AND SELL SHARES",
IS AMENDED AS FOLLOWS:
CLASS A SHARES.
Class A shares are offered at their public offering price, which is net asset
value per share plus the applicable sales charge. The sales charge varies,
depending on how much you invest. There are no sales charges on reinvested
distributions. The following sales charges apply to your purchases of Class A
shares of the Fund:
<TABLE>
<CAPTION>
SALES CHARGE AS A % SALES CHARGE AS A %
AMOUNT INVESTED OF OFFERING PRICE OF NET AMOUNT INVESTED DEALER REALLOWANCE
---------------
<S> <C> <C> <C>
Under $ 25,000 5.75% 6.10% 5.00%
25,000 to 49,999 5.25% 5.54% 4.50%
50,000 to 99,999 4.75% 4.99% 4.00%
100,000 to 249,999 3.75% 3.83% 3.00%
250,000 to 499,999 2.50% 2.56% 2.00%
500,000 to 999,999 2.00% 2.04% 1.60%
1,000,000 and above 1.00% 1.02% 0.75%
</TABLE>
If you are a participant in a qualified employee retirement benefit plan with at
least 100 eligible employees, you may purchase Class A shares without any sales
charge. However, if you redeem your shares within one year of purchase, you will
be charged a fee of 1.00% of the redemption proceeds.
Capital Research Brokerage Services, LLC, 107 South Fair Oaks Drive, Suite 315,
Pasadena, CA 91105 ("CRBS"), the Fund's principal underwriter, will pay the
appropriate dealer concession to those selected dealers who have entered into an
agreement with CRBS to sell shares of the Funds. The dealer's concession may be
changed from time to time. CRBS may from time to time offer incentive
compensation to dealers who sell shares of the Funds subject to sales charges,
allowing such dealers to retain an additional portion of the sales load. A
dealer who receives 90% or more of the sales load may be deemed to be an
"underwriter" under the Securities Act of 1933, as amended.
ALL OTHER SECTIONS OF THE PROSPECTUS NOT AMENDED BY THIS SUPPLEMENT REMAINS IN
FULL FORCE AND EFFECT.
